GB1330993A - Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease - Google Patents
Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons diseaseInfo
- Publication number
- GB1330993A GB1330993A GB88872A GB88872A GB1330993A GB 1330993 A GB1330993 A GB 1330993A GB 88872 A GB88872 A GB 88872A GB 88872 A GB88872 A GB 88872A GB 1330993 A GB1330993 A GB 1330993A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dopa
- imino
- phenyl
- mixture
- parkinsons disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title abstract 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 208000018737 Parkinson disease Diseases 0.000 title abstract 2
- NRNCYVBFPDDJNE-UHFFFAOYSA-N pemoline Chemical compound O1C(N)=NC(=O)C1C1=CC=CC=C1 NRNCYVBFPDDJNE-UHFFFAOYSA-N 0.000 title abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- -1 alkaline earth metal salt Chemical class 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11025371A | 1971-01-27 | 1971-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1330993A true GB1330993A (en) | 1973-09-19 |
Family
ID=22332021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB88872A Expired GB1330993A (en) | 1971-01-27 | 1972-01-07 | Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3686409A (enExample) |
| AU (1) | AU461236B2 (enExample) |
| CA (1) | CA964582A (enExample) |
| DE (1) | DE2203584A1 (enExample) |
| FR (1) | FR2123479B1 (enExample) |
| GB (1) | GB1330993A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7071211B2 (en) * | 2002-09-27 | 2006-07-04 | Bausch & Lomb Inc. | Small organic molecules that increase the activity of gelatinase a in ocular cells |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3108045A (en) * | 1960-03-22 | 1963-10-22 | Purdue Frederick Co | Metal chelates of oxazolidinones as central nervous system stimulants |
-
1971
- 1971-01-27 US US110253A patent/US3686409A/en not_active Expired - Lifetime
- 1971-12-30 CA CA131,414A patent/CA964582A/en not_active Expired
-
1972
- 1972-01-07 AU AU37717/72A patent/AU461236B2/en not_active Expired
- 1972-01-07 GB GB88872A patent/GB1330993A/en not_active Expired
- 1972-01-26 DE DE19722203584 patent/DE2203584A1/de active Pending
- 1972-01-27 FR FR7202755A patent/FR2123479B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU3771772A (en) | 1973-07-12 |
| US3686409A (en) | 1972-08-22 |
| FR2123479A1 (enExample) | 1972-09-08 |
| AU461236B2 (en) | 1975-05-22 |
| DE2203584A1 (de) | 1972-08-03 |
| FR2123479B1 (enExample) | 1975-02-07 |
| CA964582A (en) | 1975-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1374823A (en) | Triazolylbenzophenones | |
| GB1513704A (en) | Dyeing compositions containing dihydroxy coupling agents | |
| SE9301290D0 (sv) | Anvaendning av en somatostatinanalog | |
| ES478967A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7. | |
| GB1395090A (en) | Stabilized hormone compositions | |
| GB1370973A (en) | Therapeutic compositions | |
| AU465949B2 (en) | N-TERTIARY-4'-AMINOMETHYL-DIBENZO b,e-11-OXEPINE-2'-SPIRO-1',3'-DIOXOLANES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
| BR8008818A (pt) | Peptidos farmacologicamente ativos e medicamentos contendo os mesmos | |
| GB1341794A (en) | Medicament for the treatment of hepatic disorders | |
| IL46725A (en) | 4-o(2',6'-diamino-2',3',4',6'-tetra-desoxy-alpha d-erythrohexopyrannosyl)6-o-3"-methylamino-3",4",6"-tridesoxy alpha d-xylohexopyrannosyl)-2-desoxystreptamine and its salts and process of preparation and pharmaceutical compositions | |
| GB1330993A (en) | Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease | |
| ES388880A1 (es) | Procedimiento para la preparacion de 1-(2-nitrilofenoxi) -2- hidroxi-3-etilaminopropano racemico u opticamente activo. | |
| GB1322112A (en) | 3,4,5-trimethoxybenzoic acid derivatives and their uses | |
| IE34609L (en) | Therapeutic substituted thiazolidinedione | |
| ZA722837B (en) | Procedure for enzymatic scission of "natural penicillins and for enzymatic syntnesis of"semisynthetic"penicillins by means of an insoluble acilase and for enzymatic sciccion having similar therapeutic properties | |
| CA922691A (en) | Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts | |
| GB1354263A (en) | Therapeutic composition | |
| GB1254057A (en) | Improvements in or relating to therapeutical composition containing vincamine | |
| FR2290203B1 (enExample) | ||
| GB1353834A (en) | Benzenesulphonamides | |
| ZA74404B (en) | 4,8-dimethoxy-furo(3',2'-f)benzoxazol-2-yl acethydroxamic acid,its process of preparation and its therapeutic application | |
| GB1252861A (enExample) | ||
| GB1254125A (en) | Pharmaceutical composition suitable for the treatment of certain vascular diseases | |
| GB1036059A (en) | Improvements in or relating to the inhibition of bacterial growth | |
| GB1312204A (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |